Skip to content
Disclosery

ALPS ADVISORS INC

Follow

13F filer, CIK 1376113, Denver, CO

ALPS ADVISORS INC reported $17,336,393,056 across 1,025 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-11. Its ten largest share positions make up 59.81% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001398344-25-014895

Period
2025-06-30
Reported value
$17.3B
Holdings
1,025
Top 10 weight
59.81%
New
76
Sold out
41

Part of the filer group ALPS ADVISORS INC

  • Alerian MLP ETF
How groups are built

Stakes and trades reported after 2025-06-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • WBI WATERBRIDGE INFRASTRUCTURE L: 13G/A 12,299,138 shares, 9.96% of the class, 13G/A filed 2026-10-07, 0001398344-26-017992Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
HESMadded+2,600,295$100M
PAAadded+5,425,560$99.4M
EPDadded+1,337,043$41.5M
WESadded+851,420$32.9M
IVVadded+45,335$28.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FNDXexited-1,385,646-$32.7M
CCJreduced-275,222-$20.4M
ETreduced-1,069,707-$19.4M
FNDAexited-619,058-$17M
FNDFreduced-335,815-$13.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001398344-25-014895, largest first. % of portfolio is the value over $17,336,393,056, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 27,045 shares 27,045$222K<0.01%newTimeline
Tourmaline Bio IncTourmaline Bio IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 19,773 shares; 2024Q4: 20,735 shares; 2025Q1: 17,501 shares; 2025Q2: 13,846 shares 13,846$221K<0.01%-3,655
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 33,790 shares; 2025Q1: 28,132 shares; 2025Q2: 22,553 shares 22,553$219K<0.01%-5,579Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 27,020 shares; 2025Q1: 26,034 shares; 2025Q2: 18,048 shares 18,048$206K<0.01%-7,986Timeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 26,475 shares; 2024Q4: 29,540 shares; 2025Q1: 28,646 shares; 2025Q2: 20,653 shares 20,653$206K<0.01%-7,993
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 46,850 shares; 2025Q1: 43,086 shares; 2025Q2: 46,105 shares 46,105$206K<0.01%+3,019Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 217,178 shares; 2024Q4: 228,619 shares; 2025Q1: 210,283 shares; 2025Q2: 152,827 shares 152,827$194K<0.01%-57,456Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 74,597 shares 74,597$194K<0.01%newTimeline
ARCTARCTURUS THERAPEUTICS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,838 shares; 2024Q4: 21,901 shares; 2025Q1: 19,949 shares; 2025Q2: 14,619 shares 14,619$190K<0.01%-5,330Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 25,757 shares 25,757$179K<0.01%newTimeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 41,627 shares; 2024Q4: 43,510 shares; 2025Q1: 37,956 shares; 2025Q2: 29,028 shares 29,028$176K<0.01%-8,928Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 47,156 shares 47,156$176K<0.01%newTimeline
AVIRATEA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 64,692 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 46,165 shares 46,165$166K<0.01%newTimeline
ASTRIA THERAPEUTICS INCASTRIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 45,630 shares; 2025Q1: 43,444 shares; 2025Q2: 30,424 shares 30,424$163K<0.01%-13,020
RCREADY CAPITAL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 38,398 shares; 2024Q4: 39,794 shares; 2025Q1: 38,398 shares; 2025Q2: 37,002 shares 37,002$162K<0.01%-1,396Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 45,691 shares; 2024Q4: 46,335 shares; 2025Q1: 50,484 shares; 2025Q2: 36,910 shares 36,910$157K<0.01%-13,574Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 122,644 shares 122,644$151K<0.01%newTimeline
VNDAVANDA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,036 shares; 2024Q4: 47,149 shares; 2025Q1: 41,993 shares; 2025Q2: 31,759 shares 31,759$150K<0.01%-10,234Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 74,344 shares; 2024Q4: 86,194 shares; 2025Q1: 82,626 shares; 2025Q2: 59,201 shares 59,201$142K<0.01%-23,425Timeline
CRMLCRITICAL METALS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 15,348 shares; 2025Q1: 36,799 shares; 2025Q2: 39,674 shares 39,674$142K<0.01%+2,875Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 52,405 shares; 2024Q4: 55,332 shares; 2025Q1: 66,231 shares; 2025Q2: 50,433 shares 50,433$141K<0.01%-15,798Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 27,045 shares 27,045$137K<0.01%newTimeline
SITCSITE CTRS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,629 shares; 2024Q4: 11,015 shares; 2025Q1: 10,629 shares; 2025Q2: 10,243 shares 10,243$116K<0.01%-386Timeline
Y-mAbs Therapeutics IncY-mAbs Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 34,231 shares; 2024Q4: 36,215 shares; 2025Q1: 33,309 shares; 2025Q2: 24,429 shares 24,429$110K<0.01%-8,880
ABATAMERICAN BATTERY TECHNOLOGYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,880 shares; 2024Q4: 24,538 shares; 2025Q1: 30,028 shares; 2025Q2: 40,638 shares 40,638$65.8K<0.01%+10,610Timeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
FNDXSCHWAB STRATEGIC TR1,385,646$32.7Mshares
FNDASCHWAB STRATEGIC TR619,058$17Mshares
MAG SILVER CORPMAG SILVER CORP392,675$6Mshares
DARDARLING INGREDIENTS INC136,520$4.26Mshares
VERONA PHARMA PLCVERONA PHARMA PLC60,180$3.82Mshares
NAKNORTHERN DYNASTY MINERALS LT1,308,007$1.5Mshares
LQDALIQUIDIA CORPORATION62,656$924Kshares
WOLFSPEED INCWOLFSPEED INC242,648$743Kshares
NORDSTROM INCNORDSTROM INC28,250$691Kshares
MLYSMINERALYS THERAPEUTICS INC34,664$550Kshares
NTLAINTELLIA THERAPEUTICS INC77,328$550Kshares
BANCOLOMBIA S ABANCOLOMBIA S A11,894$478Kshares
AVBPARRIVENT BIOPHARMA INC25,167$465Kshares
PLDPROLOGIS INC.3,809$426Kshares
MONEYLION INCMONEYLION INC4,130$357Kshares
FIRST BANCSHARES INC MISSFIRST BANCSHARES INC MISS10,330$349Kshares
SVRASAVARA INC115,752$321Kshares
EASTERLY GOVERNMENT PROPERT…EASTERLY GOVERNMENT PROPERTIES25,459$270Kshares
RNACCARTESIAN THERAPEUTICS INC19,392$256Kshares
ALDXALDEYRA THERAPEUTICS INC43,803$252Kshares
AMLXAMYLYX PHARMACEUTICALS INC67,597$239Kshares
RIGLRIGEL PHARMACEUTICALS INC13,100$236Kshares
AURAAURA BIOSCIENCES INC37,156$218Kshares
PIEDMONT LITHIUM INCPIEDMONT LITHIUM INC33,637$212Kshares
ACELYRIN INCACELYRIN INC74,640$184Kshares
IRWDIRONWOOD PHARMACEUTICALS INC116,860$172Kshares
ELDNELEDON PHARMACEUTICALS INC44,436$151Kshares
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COM33,158$135Kshares
ACRSACLARIS THERAPEUTICS INC78,782$121Kshares
NMRANEUMORA THERAPEUTICS INC.114,371$114Kshares
FDMT4D MOLECULAR THERAPEUTICS IN32,811$106Kshares
LRMRLARIMAR THERAPEUTICS INC47,460$102Kshares
ALECALECTOR INC74,933$92.2Kshares
ENTAENANTA PHARMACEUTICALS INC16,257$89.7Kshares
ZNTLZENTALIS PHARMACEUTICALS INC55,033$87.5Kshares
ProKidney CorpProKidney Corp95,182$83.4Kshares
KYTXKYVERNA THERAPEUTICS INC32,126$62Kshares
MGNXMACROGENICS INC48,646$61.8Kshares
PLRXPLIANT THERAPEUTICS INC45,261$61.1Kshares
ATLXATLAS LITHIUM CORP10,779$55.7Kshares
SUTRO BIOPHARMA INCSUTRO BIOPHARMA INC61,267$39.9Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001398344-25-014895 base2025-08-11acceptance time not in the bulk data set